Calreticulin Mutations in Myeloproliferative Neoplasms: Comparison of Three Diagnostic Methods.
Calreticulin (CALR) mutations have recently been reported in 70-84% of JAK2V617F-negative myeloproliferative neoplasms (MPN), and this detection has become necessary to improve the diagnosis of MPN. In a large single-centre cohort of 298 patients suffering from Essential Thrombocythemia (ET), the JA...
Main Authors: | Ji-Hye Park, Margaux Sevin, Selim Ramla, Aurélie Truffot, Tiffany Verrier, Dominique Bouchot, Martine Courtois, Mathilde Bas, Sonia Benali, François Bailly, Bernardine Favre, Julien Guy, Laurent Martin, Marc Maynadié, Serge Carillo, François Girodon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4621046?pdf=render |
Similar Items
-
Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01) -
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
by: Marion Divoux, et al.
Published: (2020-09-01) -
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
by: Pecquet, C, et al.
Published: (2022) -
CALRETICULIN IN MYELOPROLIFERATIVE NEOPLASMS: THE OTHER SIDE OF THE ALICE MIRROR
by: Lilian Varricchio, et al.
Published: (2014-07-01) -
The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia
by: Jingyi Wang, et al.
Published: (2016-08-01)